Optimi's 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression. The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules...
Optimi's 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression. The export marks Optimi's third commercial shipment since launching the 5mg psilocybin capsules...
Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies
Recent US executive order named ibogaine compounds among the psychedelic therapies prioritized for accelerated FDA review and expanded patient access
Recent US executive order named ibogaine compounds among the psychedelic therapies prioritized for accelerated FDA review and expanded patient access
Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin...
VISTA, CA / ACCESSWIRE / March 28, 2022 / OPTEC International, Inc. (OTC PINK:OPTI) today announced a Significant Increase in Inquiries from both Private & Corporate sectors for the company's proprietary...
VISTA, CA / ACCESSWIRE / March 7, 2022 / OPTEC International, Inc. (OTC PINK:OPTI) today announced a 28% Increase in Value of the Investment Property Asset purchased less than Nine Months ago. In addition...
VISTA, CA / ACCESSWIRE / March 1, 2022 / OPTEC International, Inc. (OTC PINK:OPTI) today announced the introduction of www.Optec.io the company's new Marketplace website. The new portal will be replacing...